Table 1.
Baseline characteristics in patients with IPAF and Non-FLD
| IPAF | Non-FLD | P value | |
|---|---|---|---|
| Number, n | 64 | 41 | – |
| Age, year | 51.5 ± 13.15 | 54.7 ± 11.55 | 0.979 |
| Female, n (%) | 35 (54.69%) | 24 (58.54%) | 0.698 |
| BMI (kg/m2) | 24.33 ± 3.29 | 25.49 ± 3.46 | 0.194 |
| Smoker, n (%) | 18 (28.13%) | 12 (29.27%) | 0.899 |
| DLCO (%Pred) | 55.05 ± 12.9 | – | – |
| FVC (%Pred) | 70.11 ± 17.75 | – | – |
| FEV1 (%Pred) | 73.15 ± 16.6 | – | – |
The data are presented as means ± standard deviation. Other variables are presented as numbers (percent). IPAF Interstitial pneumonia with autoimmune features, Non-FLD non-fibrotic lung diseases, BMI body mass index, DLCO diffusing capacity for carbon monoxide, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s; %Pred, percent predicted